Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
FEBS Open Bio|January 18, 2019
Inhibins regulate peripheral regulatory T cell induction through modulation of dendritic cell functionMarisol de la Fuente-Granada, Roxana Olguín-Alor, Sandra Ortega-Francisco, et al.
FEBS Open Bio|August 30, 2025
Key role for inhibins in effective T cell activation, migration and Th17 differentiationSandra Ortega-Francisco, Roxana Olguín-Alor, Lizbeth Bolaños-Castro, et al.
Communications Medicine|February 17, 2024
Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virusFlavia Chiuppesi, John A Zaia, Miguel-Angel Gutierrez-Franco, et al.
Biochemical and Biophysical Research Communications|October 21, 2017
TβRIII is induced by TCR signaling and downregulated in FoxP3<sup>+</sup> regulatory T cellsSandra Ortega-Francisco, Marisol de la Fuente-Granada, Evelyn K Alvarez Salazar, et al.
Frontiers in Immunology|March 1, 2023
Transforming growth factor receptor III (Betaglycan) regulates the generation of pathogenic Th17 cells in EAESamuel J Duesman, Sandra Ortega-Francisco, Roxana Olguin-Alor, et al.
Blood Advances|January 10, 2022
Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunityHoda Pourhassan, Corinna La Rosa, Flavia Chiuppesi, et al.
Iscience|July 18, 2022
Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variantsFlavia Chiuppesi, John A Zaia, Katelyn Faircloth, et al.
Frontiers in Immunology|March 20, 2023
Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational studyCorinna La Rosa, Flavia Chiuppesi, Yoonsuh Park, et al.
The Lancet. Microbe|March 15, 2022
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trialFlavia Chiuppesi, John A Zaia, Paul H Frankel, et al.
Vaccines|September 28, 2023
Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular TherapyFlavia Chiuppesi, Sandra Ortega-Francisco, Miguel-Angel Gutierrez, et al.
Pageof 2